Rovelizumab Biosimilar – Anti-ITGAL, CD11a, ITGB2, CD18 mAb – Research Grade

Reference:
Size

,

Isotype

IgG4-nd

Brand

Product type

Clonality

Expression system

Applications

,

Product nameRovelizumab Biosimilar - Anti-ITGAL, CD11a, ITGB2, CD18 mAb - Research Grade
SourceCAS 339086-79-2
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsRovelizumab,Hu23F2G,ITGAL, CD11a, ITGB2, CD18,anti-ITGAL, CD11a, ITGB2, CD18
ReferencePX-TA1216
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-nd
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Rovelizumab Biosimilar – Anti-ITGAL, CD11a, ITGB2, CD18 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

ITGAL recombinant protein
Antigen

ITGAL recombinant protein

PX-P5176 394€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products